Home › Lymphoma › Tennessee › Nashville

Pag-aaral pangklinika para sa Lymphoma sa Nashville, TN

Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Nashville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Nagre-recruitPhase 2

Sarah Cannon Research Institute Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07015242

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221500

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Nagre-recruitPhase 1

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07082803

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Nagre-recruitPhase 1/2

Sarah Cannon Research Institute, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07284433

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

TriStar BMT, Nashville

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Vanderbilt-Ingram Cancer Center, Nashville

Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881

HPC Offered for PRESERVE Expansion

Nagre-recruitObservasyonal na pag-aaral

Tristar Centennial Medical Center, Nashville

Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2025 · NCT07145411

Pag-aaral para sa Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.